Literature DB >> 19765562

Characteristic response of astrocytes to plasminogen/plasmin to upregulate transforming growth factor beta 3 (TGFbeta3) production/secretion through proteinase-activated receptor-1 (PAR-1) and the downstream phosphatidylinositol 3-kinase (PI3K)-Akt/PKB signaling cascade.

Shyuichi Maeda1, Kazuyuki Nakajima, Yoko Tohyama, Shinichi Kohsaka.   

Abstract

The effects of microglia-derived plasminogen (PLGn) on the neurotrophic role of astrocytes were investigated in vitro. The treatment of astrocytes with rat PLGn led to a significant increase in transforming growth factor beta3 (TGFbeta3) in the conditioned medium (CM). This response of astrocytes to PLGn was characteristic and different from that to other stimulators, including lipopolysaccharide, phorbol-12-myristate-13-acetate, interferon-gamma, and ATP. In surveying the signaling molecules that respond to PLGn in astrocytes, we found that Akt/PKB phosphorylation is promoted. The pretreatment of astrocytes with an Akt inhibitor prior to PLGn stimulation resulted in a significant decrease in TGFbeta3 amounts in the CM, suggesting an association of Akt with TGFbeta3 production/secretion. Further survey revealed that phosphatidylinositol 3 kinase (PI3K) is closely associated with TGFbeta3 production/secretion in astrocytes. In fact, PI3K inhibitor clearly depressed the phosphorylation of Akt, indicating that PI3K is localized upstream of Akt. Moreover, the effects of PLGn to increase TGFbeta3 were depressed by pretreatment with a proteinase-activated receptor-1 (PAR-1) inhibitor. Plasmin could mimic the PLGn effects to upregulate TGFbeta3, and the plasmin effects were suppressed by pretreatment with the PAR-1 inhibitor, suggesting the association of PLGn/plasmin effects with PAR-1. In addition, Akt phosphorylation caused by plasmin was inhibited in the presence of PAR-1 inhibitor. We have therefore demonstrated that PLGn/plasmin, probably plasmin, facilitates the production/secretion of TGFbeta3 in astrocytes through both PAR-1 and the subsequent signaling cascade including PI3K and Akt.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19765562     DOI: 10.1016/j.brainres.2009.09.025

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  14 in total

1.  Human Papillomavirus 11 Early Protein E6 Activates Autophagy by Repressing AKT/mTOR and Erk/mTOR.

Authors:  Boya Zhang; Yinjing Song; Siyuan Sun; Rui Han; Chunting Hua; Stijn van der Veen; Hao Cheng
Journal:  J Virol       Date:  2019-05-29       Impact factor: 5.103

2.  Cytochrome P450 2J2 is protective against global cerebral ischemia in transgenic mice.

Authors:  Rui Li; Xizhen Xu; Chen Chen; Xuefeng Yu; Matthew L Edin; Laura Miller Degraff; Craig R Lee; Darryl C Zeldin; Dao Wen Wang
Journal:  Prostaglandins Other Lipid Mediat       Date:  2012-10-02       Impact factor: 3.072

Review 3.  Plasmin-dependent modulation of the blood-brain barrier: a major consideration during tPA-induced thrombolysis?

Authors:  Be'eri Niego; Robert L Medcalf
Journal:  J Cereb Blood Flow Metab       Date:  2014-06-04       Impact factor: 6.200

Review 4.  Role of the protease-activated receptor 1 in regulating the function of glial cells within central and peripheral nervous system.

Authors:  Elena Pompili; Cinzia Fabrizi; Francesco Fornai; Lorenzo Fumagalli
Journal:  J Neural Transm (Vienna)       Date:  2019-09-06       Impact factor: 3.575

5.  PI3K/Akt signal pathway involved in the cognitive impairment caused by chronic cerebral hypoperfusion in rats.

Authors:  Yi Shu; Hong Zhang; Tao Kang; Jun-jian Zhang; Ying Yang; Hui Liu; Lei Zhang
Journal:  PLoS One       Date:  2013-12-10       Impact factor: 3.240

6.  Interference with protease-activated receptor 1 does not reduce damage to subventricular zone cells of immature rodent brain following exposure to blood or blood plasma.

Authors:  Xiaoyan Mao; Marc R Del Bigio
Journal:  J Negat Results Biomed       Date:  2015-02-04

7.  Interference with Protease-activated Receptor 1 Alleviates Neuronal Cell Death Induced by Lipopolysaccharide-Stimulated Microglial Cells through the PI3K/Akt Pathway.

Authors:  Yuxin Li; Wuyang Yang; Alfredo Quinones-Hinojosa; Baocheng Wang; Shujun Xu; Weijie Zhu; Feng Yu; Shaoji Yuan; Peigang Lu
Journal:  Sci Rep       Date:  2016-12-02       Impact factor: 4.379

Review 8.  Protease-activated receptor-1 (PAR-1): a promising molecular target for cancer.

Authors:  Xuan Liu; Jiahui Yu; Shangjin Song; Xiaoqiang Yue; Qi Li
Journal:  Oncotarget       Date:  2017-09-18

Review 9.  Coagulation Signaling through PAR1 as a Therapeutic Target in Pancreatic Ductal Adenocarcinoma.

Authors:  Aditi Kothari; Matthew J Flick
Journal:  Int J Mol Sci       Date:  2021-05-12       Impact factor: 6.208

10.  Plasmin reduces fibronectin deposition by mesangial cells in a protease-activated receptor-1 independent manner.

Authors:  Maaike Waasdorp; JanWillem Duitman; C Arnold Spek
Journal:  Biochem Biophys Rep       Date:  2017-03-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.